Cytology Specimen Collection Procedure
Cytology Specimen Collection Procedure is an intervention with 88 clinical trials. Currently 19 active trials ongoing. Historical success rate of 80.4%.
Success Metrics
Based on 45 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
6
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
70.3%
45 of 64 finished
29.7%
19 ended early
19
trials recruiting
88
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Project: Every Child for Younger Patients With Cancer
Clinical Trials (88)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Project: Every Child for Younger Patients With Cancer
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Study of Kidney Tumors in Younger Patients
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 88